Ann: Notice of Annual General Meeting/Proxy Form, page-152

This is some campaign you're on G7, quite prolific in posting across most of threads. HJIMHO, tge bulk of the reasons you're putting up are inconsistent and ill-considered with long-term company objectives.

COVID-19 is a short-term play, yes folk that were wishing to cashout would like to see a rocketing SP, and that may still come. However, for those lookjng to maintain our investment short-term gains would be just leveled out as the Company builds is momentum.

The diagnostic field is a tedious and laboriously slow one to operate in normal circumstances. DX has no light switch that can turn on Test applications at will. Yes EUA was an inital boom for those Companies alreade in the right place. AnteoTech will still be in a position to monetise its testing platform and SARS-COV-2 AG RAT in mass screening, but more importantly place the EuGeni into the right Clinical settings to target future tests under development. There was NO RAT market to pursue in Australia - the Pollies and ATARG were steadfastly resistant to RAT applications - up until most recently. So IMHO AnteoTech took the most correct decision on targeting EuGeni placements to ensure long-term applications. Moreover AnteoTech articulated their reasoning all along the way with Updates, the time to kick up about it was way back then, even with hindsight most other paths carried significantly higher risk and wouldn’t been prudent options for the Executive to pursue in normal circumstances. Multiplex Flu & SARS will be most common, particularly in the move to betrer target treatments and minimise wholesale Antibiotic perceptions EuGeni in Clinics will be a great tool to this end.

As for Energy, consumers & (some) devices manufacturers may want better longer lasting batteries - but battery manufacturers want to sell batteries. Longer Operating life means less sales long-term & Short-term Executive salesperformance bonuses factor in new technology uptake. This is why EV companies are going in-house or acquiring stakes in Battery manufacturing. Throwing sales teams at Batteries Manufacturers is a waste of money IMHO as its the End-Users pushing the market.